ESC Premium Access

CANTOS - The Canakinumab Anti-Inflammatory Thrombosis Outcomes Study

Topic: Inflammation and microcirculation

Presentation

About the speaker

Doctor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)
25 presentations
2 followers

14 more presentations in this session

Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure, the RACE 3 study

Speaker: Professor I. Van Gelder (Groningen, NL)

Thumbnail

Discussant review: Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure, the RACE 3 study.

Speaker: Professor J. Brugada Terradellas (Barcelona, ES)

Thumbnail

Panel discussion.

Thumbnail

Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation: the CASTLE-AF trial

Speaker: Professor N. Marrouche (New Orleans, US)

Thumbnail

Discussant review: Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation: the CASTLE-AF trial

Speaker: Professor C. Blomstrom-Lundqvist (Orebro, SE)

Thumbnail

Access the full session

Hot Line: Late-Breaking Clinical Trials 1

Speakers: Doctor P. Ridker, Professor I. Van Gelder, Professor J. Brugada Terradellas, Professor N. Marrouche, Professor C. Blomstrom-Lundqvist
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk